Premium Cariprazine API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Premium Cariprazine API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Cariprazine (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Atypical Antipsychotic (Second-Generation)

Indications: Schizophrenia, Bipolar I Disorder (Mania, Mixed Episodes, and Depression)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Cariprazine distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Cariprazine is an orally active, small-molecule Active Pharmaceutical Ingredient (API). In central nervous system (CNS) pharmacology, it is classified as a second-generation (atypical) antipsychotic, utilized for the management of complex psychiatric conditions including schizophrenia and bipolar disorder.

The pharmacological profile of Cariprazine distinguishes it from other atypical antipsychotics due to its unique receptor binding affinities. It functions primarily as a partial agonist at central dopamine D3 and D2 receptors, exhibiting a nearly tenfold higher affinity for the D3 receptor compared to the D2 receptor.

In the pathophysiology of schizophrenia, D2 receptor modulation addresses positive symptoms (such as hallucinations and delusions), while D3 receptor affinity is strongly associated with regulating mood, cognition, and the negative symptoms of the disorder (such as apathy and anhedonia). Furthermore, this API acts as a partial agonist at serotonin 5-HT1A receptors and an antagonist at 5-HT2B and 5-HT2A receptors.

For pharmaceutical formulation scientists, integrating Cariprazine API allows for the development of highly targeted CNS therapeutics that address both the affective and cognitive domains of psychiatric disorders. In commercial manufacturing, this active ingredient is typically formulated into low-dose hard gelatin capsules ranging from 1.5 mg to 6 mg.

Sourcing Cariprazine in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced CNS formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty psychiatric APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. As a dedicated pharmaceutical raw material supplier, sourcing Cariprazine Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. This guarantees that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending and capsule filling processes.

Technical Specifications for QA & R&D

The Cariprazine API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 3-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-1,1-dimethylurea
• CAS Number: 839712-12-8 (Base) / 1083076-69-0 (Hydrochloride salt)
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C21H32Cl2N4O
• Molecular Weight: 427.41 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Cariprazine is a highly potent, centrally acting pharmacological compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or powered air-purifying respirators (PAPR), chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, micronization, milling, and blending stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure containment isolators to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.